Familial periodic paralyses (PPs) are inherited disorders of skeletal muscle characterized by recurrent episodes of flaccid muscle weakness. PPs are classified as hypokalemic (HypoPP), normokalemic (NormoPP), or hyperkalemic (HyperPP) according to the potassium level during the paralytic attacks. HypoPP is an autosomal dominant disease caused by mutations in the CACNA1S gene, encoding for Cav1.1 channel (HypoPP-1), or SCN4A gene, encoding for Nav1.4 channel (HypoPP-2). In the present study, we included 60 patients with a clinical diagnosis of HypoPP. Fifty-one (85%) patients were tested using the direct sequencing (Sanger method) of all reported HypoPP mutations in CACNA1S and SCN4A genes; the remaining 9 (15%) patients were analyzed through a next-generation sequencing (NGS) panel, including the whole CACNA1S and SCN4A genes, plus other genes rarely associated to PPs. Fifty patients resulted mutated: 38 (76%) cases showed p.R528H and p.R1239G/H CACNA1S mutations and 12 (24%) displayed p.R669H, p.R672C/H, p.R1132G/Q, and p.R1135H SCN4A mutations. Forty-one mutated cases were identified among the 51 patients managed with Sanger sequencing, while all the 9 cases directly analyzed with the NGS panel showed mutations in the hotspot regions of SCN4A and CACNA1S. Ten out of the 51 patients unresolved through the Sanger sequencing were further analyzed with the NGS panel, without the detection of any mutation. Hence, our data suggest that in HypoPP patients, the extension of genetic analysis from the hotspot regions using the Sanger method to the NGS sequencing of the entire CACNA1S and SCN4A genes does not lead to the identification of new pathological mutations.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Suetterlin K, Männikkö R, Hanna MG (2014) Muscle channelopathies: recent advances in genetics, pathophysiology and therapy. Curr Opin Neurol 27:583–590. https://doi.org/10.1097/WCO.0000000000000127
Maggi L, Bonanno S, Altamura C, Desaphy J-F (2021) Ion channel gene mutations causing skeletal muscle disorders: pathomechanisms and opportunities for therapy. Cells 10:1521. https://doi.org/10.3390/cells10061521
Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA et al (2018) Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve 57:522–530. https://doi.org/10.1002/mus.26009
Ke Q, Luo B, Qi M, Yue Du, Weiping Wu (2013) Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve 47:41–45. https://doi.org/10.1002/mus.23460
Horga A, Rayan DLR, Matthews E, Sud R, Fialho D, Durran SCM et al (2013) Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology 80:1472–1475. https://doi.org/10.1212/WNL.0b013e31828cf8d0
Cannon SC (2015) Channelopathies of skeletal muscle excitability. Compr Physiol 5:761–790. https://doi.org/10.1002/cphy.c140062
Wang Q, Zhao Z, Shen H, Bing Q, Li N, Hu J (2021) The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis. Channels (Austin) 15:20–30. https://doi.org/10.1080/19336950.2020.1857980
Holm-Yildiz S, Witting N, Dahlqvist J, de Stricker BJ, Solheim T, Fornander F et al (2020) Permanent muscle weakness in hypokalemic periodic paralysis. Neurology 95:342–352. https://doi.org/10.1212/WNL.0000000000009828
Li F-F, Li Q-Q, Tan Z-X, Zhang S-Y, Liu J, Zhao E-y et al (2012) A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance. J Mol Neurosci 46:378–383. https://doi.org/10.1007/s12031-011-9596-1
Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ et al (2006) The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129:8–17. https://doi.org/10.1093/brain/awh639
Jurkat-Rott K, Lehmann-Horn F (2004) Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation. Neurology 62:1012–1015. https://doi.org/10.1212/01.wnl.0000119392.29624.88
Ryan DP, Dias da Silva MR, Soong TW, Fontaine F, Donaldson MR, Kung AWC et al (2010) Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140:88–98. https://doi.org/10.1016/j.cell.2009.12.024
Marchant CL, Ellis FR, Halsall PJ, Hopkins PM, Robinson RL (2004) Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia. Muscle Nerve 30:114–117. https://doi.org/10.1002/mus.20068
Zhou H, Lillis S, Loy RE, Ghassemi F, Rose MR, Norwood F et al (2010) Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 20:166–173. https://doi.org/10.1016/j.nmd.2009.12.005
Luo S, Xu M, Sun J, Qiao K, Song J, Cai S et al (2019) Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing. BMC Neurol 19:92. https://doi.org/10.1186/s12883-019-1322-6
Groome JR, Lehmann-Horn F, Fan C, Wolf M, Winston V, Merlini L, Jurkat-Rott K (2014) NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery. Brain 137:998–1008. https://doi.org/10.1093/brain/awu015
Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J et al (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97:9549–9554. https://doi.org/10.1073/pnas.97.17.9549
Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R et al (2005) Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med 83:203–208. https://doi.org/10.1007/s00109-005-0638-4
Lin SH, Hsu YD, Cheng NL, Kao MC (2005) Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis. Am J Med 329:66–70. https://doi.org/10.1097/00000441-200502000-00003
Chabrier S, Monnier N, Lunardi J (2008) Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene. J Med Genet 45:686–688. https://doi.org/10.1136/jmg.2008.059766
Matthews E, Labrum R, Sweeney MG, Sud R, Haworth A, Chinnery PF et al (2009) Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 72:1544–1547. https://doi.org/10.1212/01.wnl.0000342387.65477.46
Ke T, Gomez CR, Mateus HE, Castano JA, Wang QK (2009) Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American Family. J Hum Genet 54:660–664. https://doi.org/10.1038/jhg.2009.92
Hirano M, Kokunai Y, Nagai A, Nakamura Y, Saigoh K, Kusunoki S et al (2011) A novel mutation in the calcium channel gene in a family with hypokalemic periodic paralysis. J Neurol Sci 309:9–11. https://doi.org/10.1016/j.jns.2011.07.046
Yang B, Yang Y, Tu W, Shen Y, Dong Q (2014) A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy. BMC Urol 14:96. https://doi.org/10.1186/1471-2490-14-96
Kurokawa M, Torio M, Ohkubo K, Tocan V, Ohyama N, Toda N et al (2020) The expanding phenotype of hypokalemic periodic paralysis in a Japanese family with p.Val876Glu mutation in CACNA1S. Mol Genet Genomic Med 8:e1175. https://doi.org/10.1002/mgg3.1175
Fan C, Lehmann-Horn F, Weber M-A, Bednarz M, Groome JR, Jonsson MKB, Jurkat-Rott K (2013) Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation. Brain 136:3775–3786. https://doi.org/10.1093/brain/awt300
Yang H, Zhang H, Xing X (2013) V876E mutation in CACNA1S gene associated with severe hypokalemic periodic paralysis in a Chinese woman. J Formos Med Assoc 114(4):377–378. https://doi.org/10.1016/j.jfma.2013.07.007
Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ et al (2009) The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet 10:104. https://doi.org/10.1186/1471-2350-10-104
Stewart SL, Hogan K, Rosenberg H, Fletcher JE (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 59:178–184. https://doi.org/10.1034/j.1399-0004.2001.590306.x
Sugiura Y, Aoki T, Sugiyama Y, Hida C, Ogata M, Yamamoto T (2000) Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. Neurology 54:179–181. https://doi.org/10.1212/wnl.54.11.2179
Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D et al (2001) Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124(1091–1099):10. https://doi.org/10.1093/brain/124.6.1091
Carle T, Lhuillier L, Luce S, Sternberg D, Devuyst O, Fontaine B, Tabti N (2006) Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis. Biochem Biophys Res Commun 348:653–661. https://doi.org/10.1016/j.bbrc.2006.07.101
Guo M, Zhang X, Ma S, Xu T, Peng Y (2018) Screening of genetic mutations in a Chinese pedigree affected with hypokalemic periodic paralysis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 35:74–77. https://doi.org/10.3760/cma.j.issn.1003-9406.2018.01.016
Li HY, Zhou XL, Guo JF, Tang BS, Fu YJ, Sun JY (2020) A novel mutation of SCN4A gene causes hypokalemic periodic paralysis in a Chinese family. Zhonghua Yi Xue Za Zhi 100:3622–3625. https://doi.org/10.3760/cma.j.cn112137-20200421-01265
Brugnoni R, Maggi L, Canioni E, Verde F, Gallone A, Ariatti A et al (2021) Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients. Neuromuscul Disord 31:336–347. https://doi.org/10.1016/j.nmd.2020.12.003
Vicart S, Sternberg D, Fontaine B, Meola G (2005) Human skeletal muscle sodium channelopathies. Neurol Sci 26:194–202. https://doi.org/10.1007/s10072-005-0461-x
This work was supported by the Italian Ministry of Health [annual research funding, years 2018–2020].
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Brugnoni, R., Canioni, E., Filosto, M. et al. Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes. Neurogenetics (2021). https://doi.org/10.1007/s10048-021-00673-2
- Hypokalemic periodic paralysis
- CACNA1S and SCN4A genes
- Sanger method
- Next-generation sequencing